Retour
Fourchette du Jour
61,24 €
63,16 €
Fourchette 52 Semaines
57,25 €
89,37 €
Volume
318 887
Moyenne 50J / 200J
65,70 €
/
67,08 €
Clôture Précédente
62,78 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 13,9 | 0,4 |
| P/B | 1,6 | 2,9 |
| ROE % | 12,3 | 3,9 |
| Net Margin % | 18,9 | 3,8 |
| Rev Growth 5Y % | 4,8 | 10,0 |
| D/E | 0,6 | 0,2 |
Objectif de Cours des Analystes
Hold
66,00 €
+6.5%
P/E Prévisionnel
13,82
BPA Prévisionnel
4,54 €
Croissance BPA (est.)
+0,0%
CA Est.
1,10B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
5,30 €
5,26 € – 5,39 €
|
1,16B | 1 |
| FY2029 |
5,12 €
5,08 € – 5,20 €
|
1,14B | 1 |
| FY2028 |
5,03 €
4,99 € – 5,07 €
|
1,15B | 2 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 4,80% annually over 5 years — modest growth
ROE of 12,30% — decent returns on equity
Net margin of 18,86% shows strong profitability
Generating 243,29M in free cash flow
P/E of 13,89 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,70%
Croissance
Revenue Growth (5Y)
4,80%
Revenue (1Y)1,10%
Earnings (1Y)2,52%
FCF Growth (3Y)4,70%
Qualité
Return on Equity
12,30%
ROIC8,77%
Net Margin18,86%
Op. Margin29,60%
Sécurité
Debt / Equity
0,57
Current Ratio4,20
Interest Coverage7,07
Valorisation
P/E Ratio
13,89
Forward P/EN/A
P/B Ratio1,62
EV/EBITDA11,66
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,10% | Revenue Growth (3Y) | 0,44% |
| Earnings Growth (1Y) | 2,52% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 4,80% | Earnings Growth (5Y) | 6,84% |
| Profitability | |||
| Revenue (TTM) | 1,14B | Net Income (TTM) | 214,61M |
| ROE | 12,30% | ROA | 6,31% |
| Gross Margin | 55,76% | Operating Margin | 29,60% |
| Net Margin | 18,86% | Free Cash Flow (TTM) | 243,29M |
| ROIC | 8,77% | FCF Growth (3Y) | 4,70% |
| Safety | |||
| Debt / Equity | 0,57 | Current Ratio | 4,20 |
| Interest Coverage | 7,07 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 13,89 | Forward P/E | N/A |
| P/B Ratio | 1,62 | P/S Ratio | 2,62 |
| PEG Ratio | 7,62 | Forward PEG | N/A |
| EV/EBITDA | 11,66 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 8,16% | ||
| Market Cap | 2,98B | Enterprise Value | 3,93B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,14B | 1,13B | 1,13B | 1,09B | 943,37M |
| Net Income | 214,61M | 209,34M | -82,31M | 205,38M | 164,68M |
| EPS (Diluted) | 4,29 | 4,17 | -1,65 | 4,04 | 3,25 |
| Gross Profit | 634,46M | 624,45M | 625,29M | 620,65M | 547,47M |
| Operating Income | 336,78M | 342,43M | -22,42M | 329,92M | 297,40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,40B | 3,32B | 3,35B | 3,67B | 3,43B |
| Total Liabilities | 1,57B | 1,66B | 1,91B | 2,09B | 2,07B |
| Shareholders' Equity | 1,83B | 1,66B | 1,45B | 1,58B | 1,36B |
| Total Debt | 1,04B | 1,14B | 1,37B | 1,51B | 1,51B |
| Cash & Equivalents | 97,88M | 46,47M | 58,49M | 27,19M | 32,30M |
| Current Assets | 448,33M | 375,04M | 391,74M | 293,27M | 269,84M |
| Current Liabilities | 106,62M | 117,05M | 160,72M | 143,42M | 122,14M |